
Prognosia Breast, an AI-driven mammography tool, receives FDA Breakthrough Device status for improved five-year breast cancer risk prediction.
Key Details
- 1FDA granted Breakthrough Device designation to Prognosia Breast, an AI mammography analysis tool.
- 2Developed by Washington University School of Medicine experts.
- 3Tool predicts five-year breast cancer risk from mammogram findings.
- 4Claims to be twice as accurate as current risk assessment methods.
- 5Aims to inform decisions on supplemental imaging and genetic testing.
Why It Matters
FDA's recognition accelerates the path for advanced AI-enabled risk assessment in breast cancer screening. Improved prediction can enhance early intervention and personalisation, potentially reducing morbidity and mortality.

Source
Health Imaging
Related News

•AuntMinnie
LLM-Based Chart Summarization Tool Reduces Radiologist Review Time
An LLM-based chart summarization tool safely reduced radiologist study review time by 17%.

•AuntMinnie
Deep Learning on PSMA-PET Scans Predicts Survival in Prostate Cancer
Deep learning models applied to PSMA-PET scans outperform existing tools in predicting two-year survival for metastatic prostate cancer.

•AuntMinnie
AI Accurately Segments Devices on Pediatric Chest X-Rays
A deep-learning model can segment and localize various devices on pediatric chest x-rays with promising accuracy.